What you believe and what you value as an organization matters. Discover the DNA of our firm.
Get to know our teams and the stories of select staff members who share why they choose to work at Sands Capital.
Read about some of the latest events, partnerships, and business highlights from Sands Capital.
Sands Capital portfolio managers reflect on five powerful lessons they have learned while investing through past downturns.
As artificial intelligence (AI) becomes a part of our everyday lives, making sure it’s transparent and unbiased has become a high priority for businesses, governments, and ordinary people. In this episode of What Matters Most, Scott Frederick, a Sands Capital managing partner, explains how software startup Credo AI is helping to keep AI models responsible. Join us as we look at how Credo AI aims to lead the way in this vital new field.
At Sands Capital we encourage our investment team to think in decades not quarters. Director of Research Michael Raab, CFA discusses how culture can support the visionary research needed to find businesses creating the future.
WEG is setting new standards for sustainability and innovation by focusing on energy efficiency and renewable solutions that deliver cutting-edge technologies to align with the needs of a rapidly changing world.
Our philosophy is rooted in the belief that, over time, stock prices will reflect the earnings power and growth of the underlying businesses.
Our latest annual report offers a comprehensive view of how we add value through active stewardship.
Our newest strategy takes an unconstrained approach to seeking the best growth businesses outside of the U.S.
Sands Capital invests in innovative businesses across all stages of the growth spectrum
Director of Technical Research
2022
Farcast Biosciences (2017-2020)
Bangalore, India | Director R&D, Intellectual Property
General Electric (2010 - 2017)
Bangalore, India | Lead Intellectual Property Professional
Brigham & Women’s Hospital, Harvard-MIT Division of Health Science and Technology (2007 - 2010)
Cambridge, MA | Post-doctoral fellow
Indian Institute of Science (2007)
PhD | Organic Chemistry
Indian Institute of Science (2002)
MS | Chemical Sciences
Padmaparna is a director of technical research on the Life Sciences Pulse strategy. She joined Sands Capital in 2022. Before joining the firm, Padmaparna spent 12 years in large multinational and start-up companies, working across life sciences tools and diagnostic programs. She has led the creation of patent portfolios and performed technology and intellectual property analysis to identify research and development and inorganic growth opportunities. Padmaparna received a PhD in bioorganic chemistry from the Indian Institute of Science and completed her postdoctoral research at Harvard Medical School/Brigham and Women’s Hospital, concentrating in targeted drug delivery in cancer.
Something has gone wrong, check that all fields have been filled in correctly. If you have adblock, disable it.
Notice for non-US Investors